Some evidence suggests potential effects on non-alcoholic fatty liver disease, though these benefits vary by specific medication and patient population
Understanding the relationship between GLP-1 therapy and hyperthyroidism helps you make informed decisions about personalized weight loss treatment
I would be on branded if it were available to me, and consistently
The obesity segment is expected to witness the fastest growth at a CAGR of 9.1% from 2026 to 2033, driven by increasing obesity prevalence and expanding regulatory approvals for weight-management indications
Medical Weight Loss Bella evaluates body composition and overall health using state of the art technology
Perimenopause, Cortisol, and GLP-1: Why Midlife Women Need Both Sides of the Equation If you are 45 to 55, on a GLP-1, and losing more slowly than the reviews promised, you are probably not a non-responder